Alternating Immune Therapy in Renal Cell Carcinoma
| Autor: | E. Bonmann, O. Witzke, Jan Kassubek, E. Musch |
|---|---|
| Rok vydání: | 1995 |
| Předmět: |
Oncology
Interleukin 2 Cancer Research medicine.medical_specialty business.industry Alpha interferon Hematology urologic and male genital diseases medicine.disease female genital diseases and pregnancy complications Immune therapy Renal cell carcinoma Internal medicine medicine Interferon gamma business neoplasms Survival rate Standard therapy medicine.drug |
| Zdroj: | Oncology Research and Treatment. 18:252-254 |
| ISSN: | 2296-5262 2296-5270 |
| DOI: | 10.1159/000218593 |
| Popis: | Background : Metastatic renal cell carcinoma (RCC) has a 5-year survival rate of about 10%. To date no standard therapy has been established for metastatic RCC. One treatment approac |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|